Webyears of the phasedown (§103(e)(4)(B)(iv)). Essential uses include inhalers for asthma, propellants for defense sprays, foams for marine and trailer use, and military and aerospace fire suppression. Stakeholders have reported a lack of chemical substitutes for the HFCs used in these applications. AIM specifies conditions under which EPA WebTitle IV-B Part 1, Child Welfare Services (CWS) of the Social Security Act was first established as part of the 1935 Social Security law. It evolved over that time from a small source of federal funding for a range of children’s services from the 1930s through the late 1950s. Until 1958, funds could not be spent in urban areas (it was assumed ...
42 CFR § 438.404 - LII / Legal Information Institute
WebSection 1886 (d) (1) (B) (iv) (I) of the Act defines a LTCH as "a hospital which has an average inpatient length of stay (as determined by the Secretary of Health and Human Services (the Secretary)) of greater than 25 days.”. Section 114 (e) of the Medicare, Medicaid, and SCHIP Extension Act of 2007 (MMSEA) added section 1886 (m) of the … WebApplication-specific allowance means a limited authorization granted in accordance with subsection (e)(4)(B)(iv) of the AIM Act for the production or import of a regulated … dgsf therapeutensuche
Higher Education Opportunity Act - 2008
WebApr 6, 2024 · In more detail, for each experiment, cells were seeded overnight at 37 °C at a density of 3 × 10 4 cells per well, in 24-well plates, until almost confluent, and then incubated for 24 h at 37 °C (5% CO 2 /saturated humidity) with 0.4 mL RPMI and 0.1 mL of the formulation evaluated in each case: (i) DOX-solution; (ii) DOX-ARSL; (iii) Empty ... WebElectronic Code of Federal Regulations (e-CFR) Title 42—Public Health; CHAPTER IV—CENTERS FOR MEDICARE & MEDICAID SERVICES, DEPARTMENT OF … WebJan 17, 2024 · (3) A statement that the applicant has received the paragraph IV acknowledgment letter for the ANDA. (4) The established name, if any, as defined in section 502(e)(3) of the Federal Food, Drug, and Cosmetic Act, of the proposed drug product. (5) The active ingredient, strength, and dosage form of the proposed drug product. cic gournay sur marne